Chinese carmaker Geely to pay US$2.4bil to take full control of Zeekr
Geely is offering US$2.69 for every share for the 892.70 million units it does not already own in Zeekr. The company currently holds around 62.80 per cent stake in Zeekr, according to a filing with the exchange.
The per American depositary share offer values Zeekr at US$6.83 billion.
The deal comes months after Geely tried to privatise the electric vehicle maker, saying it wanted to consolidate its business to counter intensifying competition.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
2 hours ago
- Malaysian Reserve
QBE North America Promotes Jordan Atkinson to President of NAU Country Insurance Company
Atkinson succeeds Jim Korin who is retiring this year NEW YORK, July 18, 2025 /PRNewswire/ — QBE North America today announced that Jordan Atkinson has been named President of NAU Country Insurance Company, effective August 18. NAU Country is QBE North America's $4 billion Crop insurance business, specializing in multiple-peril crop insurance (MPCI). Atkinson will report directly to Julie Wood, Chief Executive Officer, QBE North America, and join the Executive Management Board. 'We are thrilled to bring Jordan's deep expertise and leadership to this role at NAU Country – a leading provider of Crop insurance in the United States,' said Julie Wood, QBE North America CEO. 'Throughout his 15-year tenure, Jordan has built and fostered strong industry and agent relationships, amassed deep business and institutional knowledge, and established himself as a trusted and respected leader within our organization. This combined with his substantial technical and industry expertise will be instrumental in further strengthening the profitability and performance of NAU Country.' Atkinson succeeds long-serving NAU Country President, Jim Korin, who announced his intention to retire earlier this year. 'We are extremely grateful for Jim's 25 years of service and the invaluable leadership he has provided during his tenure at NAU Country,' Wood said. 'He has played a critical role in building the NAU Country brand as a market-leading provider of multiple-peril crop insurance. We wish him well in his upcoming retirement.' Atkinson has more than 20 years of insurance industry experience, and deep ties to agriculture and farming in the United States. He most recently served as Executive Vice President and Chief Marketing Officer of NAU Country. Before that, he held various roles of increasing responsibility across the organization's marketing, branch management and claims teams. He is a graduate of East Carolina University, where he earned a Bachelor of Science in Political Science with honors. About QBE North AmericaQBE North America is a global insurance leader helping customers solve unique risks, so they can stay focused on their future. Part of QBE Insurance Group Limited, QBE North America reported Gross Written Premiums in 2024 of $7.3 billion. QBE Insurance Group's results can be found at Headquartered in Sydney, Australia, QBE operates out of 26 countries around the globe, with a presence in every key insurance market. The North America division, headquartered in New York, conducts business primarily through its insurance company subsidiaries. The actual terms and conditions of any insurance coverage are subject to the language of the policies as issued. Additional information can be found at or follow QBE North America on LinkedIn, Facebook and Instagram. About NAU CountryNAU Country Insurance Company is a leading multi-peril crop insurance company passionate about serving the American farmer and supporting their agents in the continental U.S. Headquartered in Ramsey, MN with branch offices in 9 locations, NAU Country has grown over the years by providing outstanding customer service and leading-edge technology. NAU Country is currently licensed in 48 states and employs over 1,200 field and office staff across the country. As a division of QBE Insurance Group Ltd., one of the top 20 insurers worldwide, NAU Country has the financial strength for today's insurance environment. Visit us at for more information and follow us on Twitter, LinkedIn, and Facebook.
Malaysian Reserve
2 hours ago
- Malaysian Reserve
Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031
NEW YORK, July 18, 2025 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing significantly with the increasing prevalence of ocular diseases. The global preservative-free eye drops market is expected to reach US$1.67 billion in 2031 from US$1.21 billion in 2024. The market is estimated to grow at a CAGR of 4.3% from 2025 to 2031. The increasing prevalence of ocular diseases, the aging global population, surging awareness for chemical-free products, and supportive regulations and recommendations fuel market growth. However, limited availability of such products in the market and shorter shelf life hinder market growth. To explore the valuable insights in the Preservative Free Eye Drops Market report, you can easily download a sample PDF of the report – The preservative-free eye drops market is segmented on the basis of type, application, and distribution channel. The report runs an in-depth analysis of market trends, key players, and future opportunities. Overview of Report Findings Increasing Prevalence of Ocular Diseases: Age-related complications such as cataracts, glaucoma, and macular degeneration are among the top causes of vision loss globally. As per the report 'Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment' published in 2022, age-related macular degeneration impacts over 200 million people worldwide and is expected to reach 300 million by 2040. As per the WHO 2023, in Europe, approximately 90 million people have some form of vision impairment or blindness, representing ~9% of the population. The prevalence of these complications highlights the need for efficient eye care treatment. Preservative-free eye drops provide a safer option for people suffering from chronic eye diseases, reducing the risk of preservative-related irritation and toxicity. Rising Aging Population: With age, individuals become more prone to dry eye syndrome, glaucoma, age-related macular degeneration, and cataracts. These disorders need to be treated long-term or even for a lifetime through ophthalmic solutions. But conventional preservative-containing eye drops such as those containing benzalkonium chloride (BAK), are known to induce or worsen irritation, inflammation, and injury to the ocular surface, particularly with prolonged use. Elderly patients are susceptible to such side effects because of thinner tear films and lower regenerative capacity of the ocular surface. Preservative-free eye drops, which provide a milder and safer option, are increasingly being favored among this population. The tendency is particularly prominent in industrialized nations with an accelerating aging population, including Japan, Germany, and the US. It is also gaining prominence in China and India. Clinicians today are inclined to prescribe preservative-free drugs for older patients with chronic diseases. With the world population aged 60 and above expected to double by the year 2050, demand for safer, better-tolerated ophthalmic products will surge, driving market growth. For Detailed Preservative Free Eye Drops Market Insights, Visit: Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR in the preservative free eye drops market during the forecast period. Market Segmentation By type, the preservative free eye drops market is segmented into single dose and multiple dose. The single-dose segment held a larger share of the market in 2024, and it is anticipated to register the highest CAGR in the market during 2025–2031. Based on application, the preservative free eye drops market has been segmented into dry eye disease (DED), eye allergy/ infection, glaucoma, retinal disorders, and other indications. The dry eye disease segment held the largest share of the market in 2024 and is expected to register a higher CAGR in the market during 2025–2031. In terms of distribution channel, the preservative free eye drops market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2024. The online pharmacies segment is expected to register the highest CAGR in the market during 2025–2031. The preservative free eye drops market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. Stay Updated on The Latest Preservative Free Eye Drops Market Trends: Competitive Strategy and Development Key Players: Major companies operating in the preservative free eye drops market are Nemera, Alcon Inc., Bausch & Lomb Incorporated, Eyekare Kilitch Ltd., Essex Bio-Technology Limited, Pillar5 Pharma Inc., iVIZIA, Allergan PLC, CorneaCare Inc. Trending Topics: Dry Eye Disease (DED) Treatment, Glaucoma Therapeutics, Allergic Conjunctivitis Treatment, Contact Lens Care Products, Ophthalmic Surgical Products, Natural and Organic Eye Care Products, Pediatric Eye Care, etc. Global Headlines on Preservative Free Eye Drops Market Lumify Preservative Free Redness-Reducing Eye Drops Launch in US Alcon Announces US Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Long-Lasting Formula Purchase Premium Copy of Global Preservative Free Eye Drops Market Size and Growth Report (2021-2031) at: Conclusion The preservative free eye drops market is growing, driven primarily by the rising prevalence of chronic ocular diseases, an aging global population, and increasing consumer awareness of the adverse effects associated with preservatives. Advances in sterile packaging technologies have made preservative-free formulations more accessible and convenient. Additionally, soaring demand for safer, natural, and more tolerable eye care products aligns with broader healthcare and lifestyle trends. However, higher production costs and limited availability in certain regions limit growth. Overall, the market's future looks promising as healthcare providers and consumers prioritize ocular safety and comfort, making preservative-free eye drops a vital segment in the evolving ophthalmic therapeutics landscape. The report from The Insight Partners lists several stakeholders—including manufacturers, healthcare providers, distributors and suppliers, and regulatory bodies—along with valuable insights on how to successfully navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: The Allergy Relieving Eye Drops Market Size is expected to register a CAGR of 4.2% from 2025 to 2031 Eye Drops and Lubricants Market Size, Trends, Shares, and Forecast – 2031 Dry Eye Disease Market Size is expected to register a CAGR of 5.6% from 2025 to 2031 Diabetic Eye Disease Equipment Market Size, Trends, Shares, and Forecast – 2031 Dry Eye Disease Diagnostic Devices Market Size, Trends, Shares, and Forecast – 2031 The eye allergy treatment market size is projected to reach US$ 5.69 billion by 2030 Retinal Surgery Devices Market Size is expected to register a CAGR of 5.9% from 2025 to 2031 Retinal Implant Market Size is expected to register a CAGR of 8.4% from 2025 to 2031 The Thyroid Eye Disease Treatment Market Size is expected to register a CAGR of 6.3% from 2025 to 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us:If you have any queries about this report or if you would like further information, please contact us:Contact Person: Ankit MathurE-mail: +1-646-491-9876Press Release – More Life Sciences Research Reports & Industry Analysis – Logo: View original content:
Free Malaysia Today
4 hours ago
- Free Malaysia Today
Wall Street futures edge up as optimism over economy offsets Netflix's fall
The S&P 500 and the Dow are on track for only modest advances this week, as investors navigate a swirl of mixed signals. (AP pic) NEW YORK : US stock index futures inched higher today, buoyed by signs of a resilient US economy, even as Netflix's market-beating quarterly profit failed to dazzle investors. At 5.30am, S&P 500 E-minis were up 8.75 points, or 0.14%, Nasdaq 100 E-minis were up 33 points, or 0.14%, and Dow E-minis were up 66 points, or 0.15%. Wall Street's winning streak continued overnight, with the S&P 500 and the Nasdaq notching fresh record closes after upbeat data on retail sales and jobless claims signaled a healthy US economy. The data gives the Federal Reserve (Fed) some breathing room to assess the inflationary effects of US tariffs. Netflix rode the success of 'Squid Game' to top earnings estimates and boost its revenue outlook for the year. Yet, the streaming giant's shares slipped 1.5% in premarket trading. It has risen 43% this year. All eyes remain on whether President Donald Trump's tariff measures are starting to ripple through the economy. The Fed has signaled it will stay the course on interest rates until it sees clearer signs of how higher import taxes are shaping inflation. Traders now put the odds of a rate cut in September at about 56.3%, with a July move nearly off the table, according to CME's FedWatch tool. 'This week's data supports the wait-and-see camp on the Fed. 'Tariffs are percolating to consumer prices but is not withholding households from opening their wallets,' said Kenneth Broux, head of corporate research and rates, at Societe Generale. Fed governor Christopher Waller signaled yesterday that mounting economic risks and tame inflation have him backing an interest rate cut by this month's end, downplaying concerns that tariffs will fuel lasting price hikes. As the second-quarter earnings season gets underway, early results from 36 S&P 500 companies that reported, more than 80% have topped Wall Street's earnings expectations, according to LSEG I/B/E/S data. The S&P 500 and the Dow are on track for only modest advances this week, as investors navigate a swirl of mixed signals – robust retail sales, a spike in consumer inflation, and a stall in producer prices for June. Cryptocurrency stocks rose after the US House of Representatives passed a bill that would develop a regulatory framework for cryptocurrencies. Robinhood Markets and Coinbase Global gained 1.9% each, while Bitfarms rose 2.8% and Hut 8 advanced 1.3%.
